drugset / Trial / NCT01511692
Effect of Liraglutide Compared to Glimepiride on Appetite in Subjects With Type 2 Diabetes
RandomizedCrossoverDouble-blindTreatment
Summary
This trial is conducted in Europe and Oceania. The aim of this trial is to assess the effects of liraglutide on energy intake in subjects with type 2 diabetes.
Timeline
- Start
- 2005-11
- Primary completion
- 2007-09
- Completion
- 2007-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Glimepiride | Small molecule | — | Oral |
| Subject | Liraglutide | Peptide | 1.8 mg | Subcutaneous |